Patents by Inventor Loïc MATHIEU

Loïc MATHIEU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • AZAINDOLE DERIVATIVES AND THEIR USE AS ERK KINASE INHIBITORS
    Publication number: 20260042758
    Abstract: The present invention concerns a compound of formula (I): or one of its pharmaceutically acceptable salts, especially for use as inhibitors of the ERK kinase activity, in particular ERK2 activity.
    Type: Application
    Filed: August 28, 2025
    Publication date: February 12, 2026
    Inventors: Cédric BORIES, Loïc Mathieu, Jean-François Guichou, Muriel Gelin, Aurélien Biechy
  • Azaindole derivatives and their use as ERK kinase inhibitors
    Patent number: 12421231
    Abstract: The present invention concerns a compound of formula (I): or one of its pharmaceutically acceptable salts, especially for use as inhibitors of the ERK kinase activity, in particular ERK2 activity.
    Type: Grant
    Filed: October 6, 2023
    Date of Patent: September 23, 2025
    Assignees: AGV Discovery, Institut National de la Sante et de la Recherche Medicale (INSERM), CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS), Universite De Montpellier
    Inventors: Cédric Bories, Loïc Mathieu, Jean-François Guichou, Muriel Gelin, Aurélien Biechy
  • AZAINDOLE DERIVATIVES AND THEIR USE AS ERK KINASE INHIBITORS
    Publication number: 20240308997
    Abstract: The present invention concerns a compound of formula (I): or one of its pharmaceutically acceptable salts, especially for use as inhibitors of the ERK kinase activity, in particular ERK2 activity.
    Type: Application
    Filed: October 6, 2023
    Publication date: September 19, 2024
    Inventors: Cédric BORIES, Loïc MATHIEU, Jean-François GUICHOU, Muriel GELIN, Aurélien BIECHY
  • Azaindole derivatives and their use as ERK kinase inhibitors
    Patent number: 11827637
    Abstract: The present invention concerns a compound of formula (I): or one of its pharmaceutically acceptable salts, especially for use as inhibitors of the ERK kinase activity, in particular ERK2 activity.
    Type: Grant
    Filed: January 13, 2023
    Date of Patent: November 28, 2023
    Assignees: AGV Discovery, Institut National de la Sante et de la Recherche Medicale (INSERM), CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS), Université De Montpellier
    Inventors: Cédric Bories, Loïc Mathieu, Jean-François Guichou, Muriel Gelin, Aurélien Biechy
  • AZAINDOLE DERIVATIVES AND THEIR USE AS ERK KINASE INHIBITORS
    Publication number: 20230227451
    Abstract: The present invention concerns a compound of formula (I): or one of its pharmaceutically acceptable salts, especially for use as inhibitors of the ERK kinase activity, in particular ERK2 activity.
    Type: Application
    Filed: January 13, 2023
    Publication date: July 20, 2023
    Inventors: Cédric BORIES, Loïc MATHIEU, Jean-François GUICHOU, Muriel GELIN, Aurélien BIECHY